Jyothy Labs Share: Revenue Badhi Par Profit Margin Ki Band Baja Di!

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorKavya Nair|Published at:
Jyothy Labs Share: Revenue Badhi Par Profit Margin Ki Band Baja Di!
Overview

Jyothy Labs ke investors ke liye aaj mili-juli khabar hai. Q4 FY26 mein company ka revenue **7.7%** badhkar **₹717 crore** ho gaya, aur sales volume bhi **10.8%** bhaga. Lekin, profit **12.3%** gir gaya aur **₹67.5 crore** par aa gaya. Iska reason margin squeeze aur badhti input costs hain.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Aakhir Paisa Kahan Gaya? Volume Badhi, Profit Ghata!

Jyothy Labs ne Q4 FY26 mein revenue toh badhaya, sales volume 10.8% tak le gaye, lekin bhai, net profit 12.3% kam ho gaya. Asli picture yeh hai ki jab companies volume par focus karti hain toh kabhi kabhi margins dab jaate hain. Yeh FMCG sector mein comeback ka time hai, par Jyothy Labs ke liye thoda complicated scene hai due to raw material prices aur competition.

Revenue Badhi Par Margin Par Pressure

Last year ke Q4 se compare karein toh revenue 7.7% badhkar ₹717 crore ho gaya. Yeh sab sales volume badhane ki wajah se hua, especially modern retail aur quick commerce mein company ki reach badhi.

Par, profit seedha 12.3% girkar ₹67.5 crore par pahunch gaya. Operating EBITDA margins bhi 16.8% se ghatkar 13.5% ho gaye. Company kehti hai ki raw material, khaas karke oil related cheezon ke daam badh gaye hain, aur price hike se woh cover up nahi ho pa raha. Management ka kehna hai ki market share badhane ke liye yeh short-term pressure zaroori hai.

Competition Aur Sector Ka Mood

Jyothy Labs ka competition Hindustan Unilever (HUL) aur Marico jaise bade players se hai. Ujala mein toh 84% market share hai aur Exo, Pril mein 31%, jo ki bahut achha hai. Lekin HUL aur Marico ke paas zyada pricing power hai.

FMCG sector overall recover kar raha hai, next year volume growth aur margin improvement ki umeed hai. Lekin Jyothy Labs ko apni margin squeeze manage karni hogi. Achhi baat ye hai ki company debt-free hai aur uske paas ₹10 billion cash bhi hai. Stock ka P/E ratio 26-28 times ke aas paas hai.

Volume Strategy Ka Risk Aur Cost Ka Chakravyuh

Volume focus karne ki strategy market share toh badha sakti hai, par profitabilty par risk hai. Management ne FY27 ke liye clear profit margin guidance nahi di hai kyunki input costs fluctuate kar rahe hain. Industry ke liye margin recovery ki umeed hai, par Jyothy Labs ke liye yeh mushkil ho sakta hai. M&A (Mergers & Acquisitions) par bhi company dhyan de rahi hai, jo growth de sakta hai par execution risk bhi laata hai.

Stock apne peak se 65% gir chuka hai, jo dikhata hai ki investors profit delivery ko lekar sensitive hain.

Analysts Kya Kehte Hain?

ICICI Securities ne 'BUY' rating rakhi hai aur target price ₹310 diya hai. Unki projection hai ki FY26 se FY28 tak revenue 9.8%, EBITDA 15.7%, aur net profit 19.5% se badhega. Baaki analysts bhi mostly 'BUY' rating de rahe hain, lekin sabhi ko umeed hai ki company costs manage karegi aur volume ko profit mein badal payegi.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.